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Abstract 
The nuclear envelope (NE) is a double membrane system that is both a part of the 
endoplasmic reticulum and part of the nucleus.  As its constituent proteins tend to be 
highly complexed with nuclear and cytoplasmic components, it is notoriously difficult 
to purify.  Two methods can reduce this difficulty for the identification of nuclear 
membrane proteins: comparison to contaminating membranes and chemical 
extractions to enrich for certain groups of proteins.  The purification of nuclear 
envelopes and contaminating microsomal membranes is described here along with 
procedures for chemical extraction using salt and detergent, chaotropes, or alkaline 
solutions.  Each extraction method enriches for different combinations of nuclear 
envelope proteins.  Finally, we describe the analysis of these fractions with MudPIT, 
a proteomics methodology that avoids gel extraction of bands to facilitate 
identification of minor proteins and membrane proteins that do not resolve well on 
gels.  Together these three approaches can significantly increase the output of 
proteomics studies aimed at identifying the protein complement of subcellular 
membrane systems.   
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1. Introduction 
At the core of the nuclear envelope (NE) is a double membrane system.  One half of 
this system, the inner nuclear membrane (INM) faces the nucleus and contains many 
integral membrane proteins (1-3).  Most of these appear to be type II integral proteins 
and several have been shown to bind chromatin (4, 5) and/ or the intermediate 
filament lamin polymer that lines the INM (6).  The lamin polymer can also interact 
directly with the membrane via a farnesyl group at the C-terminus of B-type lamins 
(7) and a GNAERG group at the N-terminus of lamin C2 (8).  The other half of this 
membrane system, the outer nuclear membrane (ONM), faces the cytoplasm and, 
studded with ribosomes, is clearly a subcompartment of the endoplasmic reticulum 
(ER) (9, 10).  It contains some unique proteins that appear to connect the NE to 
cytoplasmic filament systems (11).  These two lipid bilayers connect at the pore 
membrane (PoM) where they flow around the nuclear pore complexes (NPC), large 
macromolecular assemblies that regulate the directional trafficking of soluble 
molecules between the nucleus and cytoplasm (12, 13).  Recent work suggests that the 
NPCs actively regulate trafficking of transmembrane proteins as well (14).  Between 
the ONM and INM is the lumen of the NE, which may also contain unique proteins or 
functions: for example most of the mass of the integral NPC protein gp210 resides in 
the lumen (15).  Together the ONM and associated transmembrane proteins, PoM and 
associated transmembrane proteins, lumen and associated proteins, INM and 
associated transmembrane proteins, and the connected lamin polymer constitute the 
NE. 
 Because of its inherent inner complexity and outer connectivity the NE cannot 
be purified to homogeneity, complicating efforts to identify the full complement of 
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NE proteins.  We developed a subtractive proteomics approach specifically to identify 
membrane proteins unique to the NE.  As there are no expected contaminating 
membrane structures within the nucleus, the major expected contaminant would be 
ER membranes: indeed single membrane vesicles likely to have been derived from 
vesiculated fractionated ER are observed in NE preparations by electron microscopy 
(16).  Therefore, proteins appearing in both NEs and a separately analyzed ER 
fraction are discarded from the dataset (16).  In contrast, contamination from soluble 
proteins could come from the ER, cytoplasmic filaments, or the nucleoplasm; thus it 
is not possible to choose a single contaminating fraction for subtraction.  The ER-rich 
fraction was obtained by using standard protocols for purification of microsomal 
membranes that are made completely free of nuclear membrane because the large 
intact nuclei are readily pelleted before membranes are floated on sucrose cushions 
(17, 18).  NEs are prepared by first isolating nuclei (19), then douncing to vesiculate 
other membranes that are removed by floating on sucrose cushions, and finally 
digesting chromatin to remove nucleoplasmic contents (20, 21). 
 To enrich for transmembrane proteins, NE and microsome fractions are 
extracted with either alkaline solutions (16) or chaotropes (22), which should 
solubilize cytoskeletal and chromatin components/ contaminants while leaving 
transmembrane proteins embedded in the insoluble membrane.  To enrich for proteins 
associated with the intermediate filament lamin polymer NE fractions were extracted 
with salt and detergent, as the lamina (lamins and interacting transmembrane proteins) 
is defined biochemically by its general insolubility at NaCl and Triton X-100 
concentrations of up to 1 M and 2% respectively.  Detergents solubilize membrane 
proteins by mimicking the lipid-bilayer environment.  At low concentrations they 
integrate into the lipid bilayer, but as the bilayer becomes saturated the membrane 
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disassembles to form mixed micelles.  There is no general rule for which type of 
detergent is optimal to extract a particular membrane protein or type of membrane 
protein; thus one detergent may extract a subset of both contaminants and NE proteins 
while another may extract a different subset of both.  Indeed, extraction 
characteristics differ even among lamin subtypes (23).  The variability in what each 
chemical extracts is highlighted by the minimal overlap between the proteins 
identified using alkali extraction and those identified using salt/ detergent extraction, 
yet proteins in both datasets were strongly predicted to contain membrane spanning 
segments by computer prediction and concentrated at the NE when tested by transient 
transfection of tagged versions (16).   
 To minimize loss of membrane proteins that often do not resolve well on gels 
(24), proteins were identified using MultiDimensional Protein Identification 
Technology (25-27) in which the extracted NE fraction is directly digested without 
prior separation of proteins.  The complex peptide mixture is then resolved on 
combined reverse phase and cation exchange microcapillary columns (LC/LC), 
eluting directly into ion trap tandem mass (MS/MS) spectrometers.  MS/MS datasets 
are searched for peptide sequence information using SEQUEST against a database 
combining mammalian protein sequences (28).  DTASelect is used to compile 
SEQUEST outputs into protein level information, and filter spectrum/ protein matches 
based on SEQUEST-defined parameters (29).  Multiple runs are compared using 
CONTRAST (29).  To identify transmembrane proteins within the dataset, additional 
computational algorithms are employed. 
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2. Materials2.1. Preparation of Blood Lymphocytes 
2.1.1 Hardware 
1. Buffy coats from local blood bank. 
2. Tissue-culture laminar flow hood. 
3. Standard supplies (centrifuge tubes, gloves, pipettes, scissors, tissue-culture flasks, 
etc.). 
2.1.2 Solutions 
1. Phosphate buffered saline (PBS): 4.3 mM sodium phosphate, 137 mM sodium 
chloride, 2.7 mM potassium chloride, 1.4 mM potassium phosphate. 
2. Ficoll-Hypaque 1077 density gradient medium. 
3. RPMI medium: RPMI 1640 (e.g. Cambrex 09-774), 10% fetal bovine serum, 100 U 
potassium penicillin, 100 µg/ml streptomycin sulfate, 100 µg/ml gentamicin sulfate. 
2.2. Preparation of Nuclear Envelopes 
2.2.1. Hardware 
1. Loose fitting (Wheaton type B pestle) 15 ml glass Dounce homogenizer with 
clearance of between ~0.1 and 0.15 mm (see Note 1). 
2. Swinging-bucket rotor (e.g. Beckman Coulter SW28 rotor with Beckman Coulter 
344058 Ultra-Clear 25 x 89 mm centrifuge tubes). 
3. Local standard light microscope, glass slides, and coverslips. 
4. Large bore luer lock stainless steel needles (14 gauge or larger) of greater length 
than centrifuge tubes and luer lock syringes.  
2.2.2. Solutions 
Sucrose solution names are defined by the initials for the primary components: S for 
sucrose, H for HEPES, K for KCl, and M for MgCl2 (see Note 2). 
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1. Phosphate buffered saline (PBS): 4.3 mM sodium phosphate, 137 mM sodium 
chloride, 2.7 mM potassium chloride, 1.4 mM potassium phosphate. 
2. DNase resuspended at 10 U/µl in H2O. 
3. RNase resuspended in H2O at 10 mg/ml and boiled for 20 min (see Note 3). 
4. Protease inhibitors (see Note 4): all solutions require freshly added 1 mM AEBSF 
[4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride] from a 1 M solution in 
H2O (see Note 5), 1 µg/ml aprotinin (from a 1 mg/ml stock in H2O), 1 µM pepstatin 
A [from a 1 mM stock in DMSO (dimethyl sulfoxide)], 10 µM leupeptin hemisulfate 
(from a 10 mM stock in H2O), and 10 µM 3,4-dichloro isocoumarin (e.g. Sigma 
D7910, from a 10 mM stock in DMSO).  (See Note 6.) 
5. Hypotonic lysis buffer: 10 mM HEPES pH 7.4, 1.5 mM MgCl2, 10 mM KCl, and 
freshly added 2 mM DTT (dithiothreitol; from a 1 M solution in H2O) and protease 
inhibitors.  
6. 0.25 M SHKM: 50 mM HEPES pH 7.4, 25 mM KCl, 5 mM MgCl2, 250 mM 
sucrose, and freshly added 1 mM DTT and protease inhibitors.   
7. 2.2 M SHKM: 2.2 M Sucrose, 50 mM HEPES pH 7.4, 25 mM KCl, 5 mM MgCl2, 
and freshly added 1 mM DTT and protease inhibitors (see Note 7). 
8. 30% SHKM: 0.9 M Sucrose, 50 mM HEPES pH 7.4, 25 mM KCl, 5 mM MgCl2, 
and freshly added 2 mM DTT and protease inhibitors.  This can also be prepared by 
mixing 67 ml 0.25 M SHKM with 33 ml 2.2 M SHKM. 
9. 30% SHM buffer: 0.9 M sucrose, 10 mM HEPES pH7.4, 2 mM MgCl2, 0.5 mM 
CaCl2, and freshly added 2 mM DTT and protease inhibitors. 
10. 10% SHM buffer: 0.3 M sucrose, 10 mM HEPES pH7.4, 2 mM MgCl2, 0.5 mM 
CaCl2, and freshly added 2 mM DTT and protease inhibitors. 
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2.3. Preparation of Microsomal Membranes 
2.3.1. Hardware 
1. The same hardware is required as for Preparation of Nuclear Envelopes. 
2. A type 45 Ti fixed angle rotor or equivalent that can provide 150,000 x g and 
matching tubes (e.g. Beckman-Coulter 348176). 
2.3.2. Solutions 
The same sucrose solutions used for Preparation of Nuclear Envelopes can be used in 
preparing microsomes.  In particular the 2.2 M SHKM, 0.25 M SHKM, and a mixture 
of the two to 1.86 M sucrose will be required. 
 
2.4. Chemical Extractions 
2.4.1. Hardware 
1. TLA100.3 rotor for table-top ultracentrifuge or equivalent and corresponding tubes 
(e.g. Beckman-Coulter 343778 polycarbonate 11 x 34 mm tubes). 
2.4.2. Solutions 
1. Salt wash: 50 mM HEPES pH 8.0, 500 mM KCl, 5 mM MgCl2 with freshly added 
2 mM DTT and protease inhibitors.2. Alkaline extraction: 0.1 N NaOH, 1 mM DTT 
in H2O.3. Salt/ Detergent extraction(i). Triton X-100 resuspended at 1% in a solution 
containing 25 mM HEPES pH 7.5, 400 mM NaCl.(ii). Octyl ß-D-glucopyranoside 
(also called n-Octyl glucoside) resuspended at 1% in a solution containing 25 mM 
HEPES pH 7.5, 400 mM NaCl. 
(iii). Empigen BB resuspended at 0.3% in a solution containing 25 mM HEPES pH 
7.5, 400 mM NaCl. 
4. Chaotrope extraction: 0.1 M Na2CO3, 4 M urea. 
2.5. Digestion of Proteins 
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2.5.1. Hardware 
1. Eppendorf Thermo Mixer R and Thermo mixer R block for 1.5 ml tubes. 
2. pH Indicator Strips, 7.5 to 14. 
2.5.2. Solutions 
1. 90% Formic Acid. 
2. Cyanogen Bromide at 500 mg/ml in 90% Formic Acid. 
3. Ammonium Hydroxide solution, NH4OH, in water at 0.9 g/ml density. 
4. Urea, solid. 
5. HPLC grade water. 
6. Tris(2-Carboxylethyl)-Phosphine Hydrochloride, TCEP (e.g. Pierce, 20490), as a 1 
M stock in HPLC grade water, stored at -20oC. 
7. Iodoacetamide, IAM, made fresh weekly as a 500 mM stock in HLPC grade water, 
and stored at -20 oC. 
8. Hydrochloric acid, HCl  
9. Tris base, as a 1 M solution in HPLC grade water, pH adjusted to 8.5 with HCl, 
stored at 4oC. 
10. Endoproteinase LysC, sequencing grade, as a 1 µg/µl stock in in HPLC grade 
water, stored at -20oC. 
11. Calcium chloride as a 500 mM stock in HPLC grade water, stored at room 
temperature. 
12. Trypsin, modified sequencing grade, as a 0.1 µg/µl stock in HPLC grade water, 
stored at -20oC.   
 
2.6. Microcapillary Column Preparation 
2.6.1. Hardware 
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1. Laser Puller (e.g. Model P-2000 Sutter Instrument Co). 
2. Polyimide coated fused silica, 50 µm i.d. x 365 µm o.d. (e.g. Polymicro 
Technologies, TSP 050375). 
3. Polyimide coated fused silica, 100 µm i.d. x 365 µm o.d. (e.g. Polymicro 
Technologies, TSP 100375). 
4. Polyimide coated fused silica, 250 µm i.d. x 365 µm o.d. (e.g. Polymicro 
Technologies, TSP250350). 
5. Column Scribe (e.g. Chromatography Research Supplies, 205312). 
6. M-520 Inline Micro Filter Assembly (e.g. UpChurch Scientific, M-520). 
7. 0.5 µm PEEK Filter end fitting (e.g. UpChurch Scientific, M-120X). 
8. Microtight 395 µm Sleeves (e.g. UpChurch Scientific, F-185X). 
9. Pressurization Device (Brechbuehler, Inc., Houston, TX, or MTA for blueprints 
available by request from John Yates, Scripps Research Institute, La Jolla, CA). 
10. Agilent 1100 series G1379A degasser, G1311A quaternary pump, G1329A 
autosampler, G1330B autosampler thermostat, and G1323B controller (Agilent 
Technologies, Palo Alto, CA). 
2.6.2. Solutions 
1. HPLC grade Methanol  
2. HPLC grade Acetonitrile  
3. 90% Formic Acid  
4. HPLC grade water  
5. Ammonium Acetate  
6. C18 Aqua Reversed Phase, 5 µm (e.g. Phenomenex, bulk material, 04A-4299). (See 
Note 8.) 
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7. Partisphere Strong Cation Exchange, 5 µm (e.g. Whatman, WC4621-1507; see 
Note 9). 
8. Buffer A: 5% Acetonitrile, 0.1% formic acid, in HPLC grade water. 
 
2.7. Multidimensional Chromatography Coupled to Tandem Mass Spectrometry 
2.7.1. Hardware 
1. LCQ DECA-XPplus tandem mass spectrometer (Thermo Electron, San Jose, CA). 
2. Nano electrospray stage (e.g. Thermo Electron Nanospray II ion source or 
PicoView Source from New Objective). 
3. MicroTee Assemblies (e.g. UpChurch Scientific, P-775). 
4. Micro Ferrule for 360 µm OD tubing (e.g. UpChurch Scientific, F-152). 
5. Gold wire 0.025 in diameter (e.g. Scientific Instrument Services, W352). 
2.7.2. Solutions 
1. Buffer A: 5% acetonitrile, 0.1% formic acid, in HPLC grade water. 
2. Buffer B: 80% acetonitrile, 0.1% formic acid, in HPLC grade water. 
3. Buffer C: 500 mM ammonium acetate, 5% acetonitrile, 0.1% formic acid, made 
with HPLC grade water and filtered. 
 
2.8. Analysis of MS/MS Dataset 
Linux Computer cluster (over 100 nodes) dedicated to SEQUEST analysis. 
 
2.9. Determination of Transmembrane Proteins 
Many computer algorithms that can be used to predict transmembrane proteins are 
freely available online and discussed elsewhere in this volume.  Those we typically 
use are listed: 
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1.  TMHMM “http://www.cbs.dtu.dk/services/TMHMM-2.0/” 
2.  TMPred “www.ch.embnet.org/software/TMPRED_form.html” 
 
 
3. Methods 
The first step in NE enrichment is the isolation of nuclei from other cellular proteins 
and membranes.  Factors critical to this process are the size ratio of nucleus to 
cytoplasm, the concentration of cytoplasmic filament systems, and nuclear density, 
which all vary among different tissues.  The protocol described here is one we have 
optimized for purifying NEs from human blood leukocytes (generally 60-80% 
lymphocytes) (see Note 10).  We generally recover ~65 million NEs from one buffy 
coat (~100 million leukocytes; see Note 11). 
 
3.1. Preparation of Blood Lymphocytes 
1.  Buffy coats are obtained from a blood bank according to local permissions and 
protocols.  If dealing with more than one buffy coat at a time it is important to keep 
them separate until Sect. 3.2.7, otherwise the mixed lymphocyte activation response 
can rapidly alter expression profiles and cells may aggregate, forming rosettes. 
2.  Open six 50 ml conical tubes (e.g. Falcon™ Conical Centrifuge Tubes, 50 ml 
capacity) in a laminar flow cabinet/ tissue culture hood (see Note 12). 
3. Wipe scissors and blood bag with 70% EtOH.  Cut one of the strands of tubing 
coming from the bag while holding upright.  Tilt end of tube over first 50 ml conical 
tube and pour 12.5 ml into each tube using tilt angle to regulate gravity flow. 
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4. Dilute blood with 4 volumes PBS (50 ml total per tube that has a full 12.5 ml of 
blood).  Calculate the total volume and divide by 15: this gives the number of tubes 
required for step 5. 
5. Pour 15 ml of Ficoll-Hypaque 1077 media into fresh tubes. 
6. Gently overlay with 15 ml of diluted blood (see Note 13).  
7. Centrifuge at 400 x g for 30 min at RT. 
8. Three layers will be obtained after centrifugation: the middle layer containing 
principally lymphocytes should appear cloudy white (see Note 14).  Carefully 
dispense of the upper layer with a pipette.  Collect all the intermediate phase (on 
average 4-6 ml) into a new tube, taking care to disrupt any clumps. 
9. Dilute the material with 4 volumes of PBS and centrifuge at 250 x g for 10 min at 
RT (see Note 15). 
10. Resuspend each pellet in 25 ml PBS, combine (two tubes into one), and centrifuge 
at 250 x g for 10 min at RT (see Note 16). 
11. Resuspend each pellet in RPMI medium and transfer into 75 cm2 tissue culture 
flasks (see Note 17). 
12. One buffy coat will generally yield ~120 million leukocytes and can be seeded at 
between one and ten million cells per ml. 
 
3.2. Preparation of Nuclear Envelopes 
1. Count cell number and pellet (in 50 ml tubes) at 250 x g for 10 min at room 
temperature (see Note 18). 
2. Carefully and completely decant supernatant and resuspend the pellet from each 
blood pack from step 1 in 0.5 ml ice cold PBS by gentle agitation (see Note 19).  
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Accumulate so each tube has ~25 million cells and add additional PBS to 30 ml (see 
Note 20). 
3. Withdraw a 10 µl sample for microscopic analysis, then pellet the rest at 250 x g 
for 10 min at 4°C. 
4. Pour off buffer carefully by inversion, carefully re-right the tube, and let PBS 
settle.  Remove the remaining PBS with a pipette tip.  Place pellets on ice and 
resuspend the first pellet in 7 ml ice cold hypotonic lysis buffer with freshly added 
DTT and protease inhibitors (see Note 21).  Let incubate on ice for 10 min, following 
an aliquot under the microscope throughout (see Note 22).  Good swelling is depicted 
in Figure 1: compare panel A (before swelling) with panel B (swelling).  When such a 
state is reached, the Dounce step (6) should be performed. 
5. Five minutes after resuspension of the first pellet, similarly resuspend the second 
pellet (see Note 23). 
6. When the 10 min incubation is complete, cells should be moved to the 15 ml loose 
Dounce homogenizer and lysed by 10 vigorous strokes.  Immediately add 1/10 
volume of 2.2 M SHKM and 1/10 volume of 1 M KCl (see Note 24). 
7. Remove to centrifuge tubes and underlay with a cushion of 1/10th volume 30% 
SHKM using a 14 gauge needle and syringe.  Pellet nuclei at 2,000 x g in a swinging 
bucket rotor (e.g. 4,000 rpm in a Beckman Coulter J6-MC floor model centrifuge) for 
20 min at 4°C. 
8. Decant the supernatant and resuspend pellets in 11 ml 0.25 M SHKM.  If they 
appear at all aggregated, give a few sharp strokes in the Dounce homogenizer with the 
loose pestle to uniformly resuspend them.  Add 2.2 M SHKM to a final concentration 
of 1.9 M sucrose (39 ml).  (See Note 25). 
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9. Dispense 25 ml into each SW28 ultracentrifuge tube and underlay with 5 ml of 2.3 
M SHKM using a 14 gauge needle in a luer lock syringe (Figure 2).   
10. Balance the tubes by exchange between the upper nuclei-enriched lysate phase 
and spin in the SW28 rotor for 2 h at 82,000 x g (25,000 rpm). 
11. Move to a cold room and remove any floating white material with a spatula, then 
pour off the rest of the supernatant by rapid inversion.  Keep the tubes upside down in 
the cold for 10 min to drain them.  Then gently wipe out the inside walls of tubes with 
a folded kimwipe (or equivalent towel), being very careful not to touch the pellet (see 
Note 26). 
12. Resuspend each pellet in a small volume (~2 ml) of 0.25 M SHKM with freshly 
added 2 mM DTT and protease inhibitors, being careful to avoid touching the walls. 
13. Dounce to break the aggregates of nuclei and transfer into an ice-cooled 15 ml 
conical tube.  Wash the homogenizer with 1 ml 0.25 M SHKM and add to the 
resuspended nuclei. Take a small aliquot for counting nuclei (step 14) and another to 
place on a slide for step 16.  
14. Count nuclei using a hemocytometer and calculate the total number from the 
volume currently spinning in the centrifuge.  The nuclei should be clean of 
contaminating cell fragments and appear as in Figure 3A. 
15. Resuspend in 10% SHM with freshly added 2 mM DTT and protease inhibitors at 
1.5 million nuclei/ml.  Add 4 U/ml DNase and 1 µg/ml RNase and incubate at room 
temperature for 15 min.  Transfer into ice cooled tubes and centrifuge at 6,000 x g 
(~5,000 rpm) in a floor model intermediate speed centrifuge with a swinging bucket 
rotor (e.g. Beckman-Coulter J6-MC) for 10 min at 4°C. 
16. Resuspend the pellet in 10% SHM with freshly added 2 mM DTT and protease 
inhibitors at 3 million nuclei/ml.  Dounce if necessary, transfer into a 15 ml conical 
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tube. Add 8 U/ml DNase and 2 µg/ml RNase and incubate at room temperature for 15 
min.  Observe digestion on the microscope in parallel.  The phase grey of the nuclei 
should diminish (Figure 3, compare A and B). 
17. When 90% of nuclei are no longer phase-grey, underlay the solution with 30% 
SHM with freshly added DTT and protease inhibitors.  Spin for 30 min at 6,000 x g 
using a swinging bucket rotor (e.g. 5,000 rpm in a Beckman-Coulter floor model J6-
MC centrifuge; see Note 27). 
18. Carefully aspirate off the supernatant (do not decant by pouring) as the pellet will 
be very soft (see Note 28). 
19. Resuspend the pellet in the same volume of 10% SHM.  Withdraw a 10 µl sample 
and count NEs using a hemocytometer to calculate the yield of the prep: 
percentage yield is calculated as (final number of NEs/total number initial cells) x 
100. 
20. Although there is no time during the digestion to stain nuclei with DAPI or 
Hoechst dyes to visualize more directly the extent of chromatin digestion, if this is 
desired samples can be taken at this point and fixed for later staining.  The loss of 
chromatin observed by phase contrast light microscopy (Figure 3A and B) can be 
more clearly observed by DNA staining (Figure 3C and D). 
21. Aliquot the NEs to centrifuge tubes (chosen for desired storage method and 
concentration) and spin at 6,000 x g (5,000 rpm) for 10 min (no cushion) at 4°C (see 
Note 29). 
22. Carefully aspirate the supernatants and immediately flash-freeze in liquid nitrogen 
and store at -80°C. 
 
3.3. Microsomal Membrane Purification  
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Because lymphocytes have very little cytoplasm to produce microsomes, we instead 
used the HL-60 human cell line that can be induced into different blood cell lineages.  
Treatment with phorbol esters induces differentiation into megakaryocytes with 
associated attachment and spreading of the cells.  We predicted that this would 
produce microsomes in sufficient quantity while being largely similar in protein 
composition to the lymphocyte ER.    
1. Seed 1 x 107 HL-60 cells per 10 cm tissue culture dish. 
2. Add PMA (Phorbol 12-myristate acetate; Calbiochem 524400) from a 5 mg/ml 
stock in acetone to a final concentration of 1 µg/ml. 
3. When the cells have adhered and spread (2-3 days), collect by scraping with a 
teflon cell scraper, transfer into a centrifuge tube, and pellet at 250 x g for 10 min. 
4. Wash once in PBS and collect again by centrifugation.  
5. Follow steps 4-7 in Preparation of Nuclear Envelopes (section 3.2).  
6. Recover the supernatant from Preparation of Nuclear Envelopes step 7 and add 
EDTA to 0.5 mM to inhibit metalloproteinases.  Centrifuge at 10,000 x g for 15 min 
to remove mitochondria (see Note 30). 
7. Mix the post-mitochondrial supernatant with 5 volumes (e.g. 1 ml + 5 ml) of 2.2 M 
SHKM (with 0.5 mM EDTA, 2 mM DTT, and protease inhibitors) to achieve a final 
sucrose concentration of roughly 2 M. 
8. Float the microsomes by pouring 20 ml of the diluted membranes in each SW28 
rotor tube and overlay with 6 ml of 1.86 M SHKM with 0.5 mM EDTA, 2 mM DTT, 
and protease inhibitors.  Finally, overlay this with 2.3 ml of 0.25 M SHKM with 0.5 
mM EDTA, 2 mM DTT, and protease inhibitors.  Centrifuge at 57,000 x g (21,000 
rpm) in type 45 Ti rotor for 4 h (see Note 31).   
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9. The microsomes will be in the interface beween the 1.86 M and 0.25 M sucrose 
layers and should appear largely white and translucent.  There will be material in and 
above the 0.25 M layer, which should be discarded; thus it is best to remove material 
by tube puncture from the side though a syringe inserted between the layers from the 
top.   
10. Dilute the membranes with 4 volumes of 0.25 M SHKM (with 0.5 mM EDTA, 
freshly added DTT and protease inhibitors) and pellet at 152,000 x g (44,000 rpm in a 
type 45 Ti, 48,000 rpm in a type 50 Ti, or 60,000 rpm in a TLA100.3 rotor) for 75 
min (see Note 32).  There should be a translucent pellet with the appearance of a fat 
droplet in the corner of the tube.  Decant supernatant and store at -80°C. 
 
3.4. Chemical Extractions 
It is wise to check an aliquot of the NE preparation by Coomassie blue stained SDS-
PAGE as “Purified” NEs often contain a prominant histone band indicating a large 
degree of chromatin contamination.  If this is the case, they may be salt washed prior 
to further chemical extraction.  Formulas for the chemicals used to extract are 
depicted in Figure 4.  
3.4.1. Salt wash 
1. To salt wash, resuspend the NE pellet in the salt wash solution at ~5 million 
NEs/ml and let stand on ice 15 min with occasional mixing. 
2. Pellet by centrifugation at 20,000 x g (~14,000 rpm) in a cooled microcentrifuge 
for 30 min and decant supernatant. 
3.4.2. Alkali (NaOH) extraction 
1. Resuspend NEs (no more than 10 million/ml or an equivalent amount of 
microsomes, see Note 33)  in 0.1 M NaOH on ice.   
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2. Transfer immediately to TLA100.3 ultracentrifuge tubes and pellet insoluble 
material at 104,000 x g (50,000 rpm) for 35 min at 4°C (see Note 34).   
3. Wash the pellet quickly with double distilled H2O (see Note 35).   
4. Either freeze at -80°C or directly process for mass spectrometry. 
3.4.3. Extraction with salt and detergent   
1. Resuspend NE pellet in any salt/ detergent buffer at no more than 10 million NEs/ 
ml and incubate on ice for 15 min with occasional mixing. 
2. Pellet by centrifugation at 20,000 x g (~14,000 rpm) in a cooled microcentrifuge 
for 30 min and decant supernatant.  
3. Wash the pellet with the same buffer minus detergent, re-pellet, and either freeze at 
-80°C or directly process to digest for mass spectrometry. 
3.4.4. Chaotrope extraction 
1. Resuspend the pellet in chaotrope buffer and incubate on ice for 15 min.  
2. Pellet the insoluble material in a TLA100.3 table top ultracentrifuge rotor or 
equivalent at 104,000 x g (50,000 rpm) for 35 min at 4°C. 
3. Wash the pellet with double distilled H2O and either freeze at -80°C or directly 
process to digest for mass spectrometry. 
 
3.5. Digestion of Proteins 
As described in (26), the membrane pellets were first partially solubilized in formic 
acid and cyanogen bromide to chemically cleave large portions of proteins, before 
digesting these larger peptides with endoproteinase Lys-C and trypsin.  
1. On day one, resuspend the dried membrane pellets in 100 µl of CNBr at 500 mg/ml 
in 90% formic acid, mix by pipetting and leave under a fume hood overnight in the 
dark (for example, in a cardboard freezer box). 
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2. On day two, transfer 100 µl of partially solubilized membranes to a 15 ml conical 
tube on ice (see Note 36), and add NH4OH drop by drop to neutralize formic acid 
until there is no more bubbling and the pH is ~8.5 (check after every 100 µl added 
with 1 µl using pH indicator strips).  Once the appropriate pH is reached, the sample 
can be transferred back to a 1.5 ml tube. The final volume should be around 500 µl, 
i.e. a 3- to 5-fold dilution. 
3. Add solid urea to 8M (taking into account the fact that adding urea will cause the 
volume to increase to about 800 µl) and then add TCEP to  a final concentration of 5 
mM. Allow the reduction to proceed at room temperature for 30 min, then add IAM to 
20 mM, and let the carboxiamidomethylation of free cysteines proceed for 30 min at 
room temperature in the dark. 
4. Re-check the pH at this step using pH indicator strips and adjust with 1 M Tris-HCl 
pH 8.5 if necessary before adding endoproteinase Lys-C at 1 µg/µl for an estimated 
enzyme to protein ratio of 1:100 (w/w).  Let the digestion proceed at 37°C, for at least 
6 h. 
5. Dilute the digestion mix to 2 M urea by adding 0.1 M Tris-HCl, pH 8.5. (See Note 
37.)  Add CaCl2 to 2 mM, then trypsin at 0.1 µg/µl for an estimated enzyme to protein 
ratio of 1:100 (w/w).  Let the reaction proceed overnight at 37°C. 
6. On day three, quench the reaction by adding formic acid to 5%.  Either store the 
peptide mixtures at -20°C or load directly onto microcapillary columns. 
 
3.6. Microcapillary Column Preparation 
The large final sample volume (3 x 1150 µl) would take a very long time to load onto 
traditional 100 µm columns, so we use the “split” column approach (Figure 6), in 
which the sample is loaded onto larger diameter open-ended columns packed with 
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reverse phase and strong cation exchange resins, before being connected to a 
resolving 100 µm column packed with reverse phase (see (30)) for a detailed 
description of the following steps).  
3.6.1. Single-Phase Fused-Silica 100 µm Microcapillary Column 
1. Place 40 cm of 100 µm i.d. x 365 µm o.d. fused silica into P-2000 laser puller and 
pull tip to about a 5 µm opening. 
2. Make a slurry of 5 µm C18 Reverse Phase (Aqua Phenomenex), at 15 mg/ml in 500 
µl methanol. 
3. Pack fused silica column with 8-9 cm of 5 µm C18 RP using high pressure loading 
device. 
4. Wash with methanol for at least 10 min. 
5. Equilibrate in Buffer A for at least 30 min. 
3.6.2. Double-Phase Fused-Silica 250 µm Microcapillary Column 
1. Connect two 250 µm i.d. x 365 µm o.d. fused silica capillaries (about 30 cm) with a 
2 µm filtered union. 
2. Make slurries of 5 µm C18 Reverse Phase (Aqua Phenomenex) and of 5 µm strong 
cation exchange material (Partisphere SCX, Whatman), both at 15 mg/ml in 500 µl 
methanol. 
3. Pack first with 3 to 4 cm of Partisphere SCX, followed by 2 to 3 cm of Aqua RP. 
4. Wash with methanol for at least 10 min. 
5. Equilibrate in buffer A for at least 30 min. 
3.6.3. Off-Line Loading and Desalting 
1. Spin samples down at 14,000 rpm for 30 min and transfer to a new tube. 
2. Load sample to 250 µm column. 
3. Wash with Buffer A (1.5 ml). 
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4. Connect 250 µm i.d. column to equilibrated 100 µm double-phase column. 
 
3.7. Multidimensional Chromatography Coupled to Tandem Mass Spectrometry 
3.7.1. Chromatography 
1. Install the loaded and washed split-3-phase microcapillary column on the 
nanoelectrospray stage (Figure 6D), connecting it with the quaternary HPLC pump 
using a microtee.  
2. Cut the overflow 50 µm fused silica capillary to the appropriate length (about 40 
cm) to have a flow rate at the tip of the column of about 200-300 nl/min (i.e. back 
pressure of ~40 bars), while the HPLC flow rate is kept constant at 0.1 ml/min 
throughout the chromatography. 
3. Engage a 12-step chromatography run (24 h) on samples with the gradient 
parameters described in Table 1. In such sequences of chromatographic events, 
peptides are sequentially eluted from the SCX resin to the RP resin by increasing salt 
steps (increase in Buffer C concentration), followed by organic gradients (increase in 
Buffer B concentration). For the last chromatography step, wash in high salt with 
100% Buffer C, followed by the acetonitrile gradient (repeated twice). 
4. Apply a 2.4 kV voltage to the eluting peptides via a gold wire connecting the 
microtee and the mass spectrometer. 
3.7.2. Tandem Mass Spectrometry 
Chromatographic gradients and MS/MS data acquisition are controlled by the 
XcaliburTM data system.  For runs performed on LCQ-Deca tandem mass 
spectrometers, the acquisition scheme is a cycle of one full MS scan (from 400 to 
1600 m/z), followed by three MS/MS events at 35% collision energy on the top three 
most intense ions.  Dynamic exclusion is enabled for 5 min, allowing ions of lesser 
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intensities to be analyzed.  This cycle is repeated continuously throughout the 
chromatography. One RAW file is generated for each chromatographic step and needs 
to be converted into a dat file using the XCalibur file converter function. 
 
3.8. Analysis of MS/MS Dataset 
1. Convert each dat file into a ms2 file (31) using extract-ms followed by 2to3 (32) to 
remove spectra of poor quality and assign a charge state to the precursor ion when 
possible. 
2. Use SEQUEST (28) to search the MS/MS datasets against a database of sequences 
downloaded from NCBI (National Center for Biotechnology Information).  We 
combined 27,960 human, 26,180 mouse, 21,205 rat, 21,909 chimp, 5,373 orangutan, 
903 gorilla and 2,777 macaque protein sequences on 2005-02-17, and complemented 
with 172 sequences from usual contaminants (human keratins, IgGs…).  (See Note 
38.) 
3. Bring together the peptide information contained in the SEQUEST output files and 
organize these into protein level information using DTASelect (29).  DTASelect is 
also used to select and sort peptide/spectrum matches passing the criteria defined in 
Table 2.  In particular, the validity of peptide/spectrum matches is assessed using the 
SEQUEST-defined parameters, cross-correlation score (XCorr) and normalized 
difference in cross-correlation scores (DeltCn).  Spectra/peptide matches are only 
retained if they have a DeltCn of at least 0.08 and minimum XCorr of 1.8 for singly-, 
2.5 for doubly-, and 3.5 for triply-charged spectra.  In addition, the peptides have to 
be at least 7 amino acids long and the preceding residue in the protein sequence has to 
be a methionine, an arginine or a lysine (to account for the combined cyanogen 
bromide/trypsin digestion protocol).   
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4. Compare protein lists from multiple runs using CONTRAST (29).  Although some 
argue that at least two peptides should be recovered for higher confidence, we allow 
single peptide identifications in the final dataset because some well-characterized 
NETs were also detected by single peptides in previous studies, likely indicating their 
lower abundance (16).  
5. Additional utilities of DTASelect/CONTRAST are used to create subset databases 
in Fasta format containing only the proteins in the final list and to generate tab-
delimited text files that can be consolidated into relational databases using MSAccess. 
 
3.9. Determination of Transmembrane Proteins 
Use Fasta format protein sequence files to search for predicted transmembrane 
segments using various algorithms.  These are detailed elsewhere in this volume (see 
Note 39). 
 
 
4. Notes 
1. In section 3.2.2 the number of leukocytes aliquoted for each Dounce step should be 
correspondingly altered if a smaller or larger Dounce homogenizer is used. 
2. MgCl2 concentration in the original procedure was 5 mM throughout; however if 
NEs are being prepared for viewing by electron microscopy, dropping the 
concentration through most of the procedure to 0.1 mM will yield better structure.  If 
this is done, the MgCl2 must be increased back to 5 mM, or to 2 mM with 0.5 mM 
CaCl2 as we use, during DNase and RNase treatment for the enzymes to function 
properly. 
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3. This may seem counter-intuitive as the goal of the procedure is to degrade both 
RNA and DNA, but these enzymes are commonly prepared from bovine pancreas and 
therefore may have contaminating proteases unless recombinant proteins are used. 
4. The optimal protease inhibitors will vary according to the tissue being investigated; 
so it is important to search the literature to determine what proteases are present at 
high concentrations in the tissue of choice.  The choice for blood covers a wide 
general range (inhibiting serine, trypsin, cysteine, and aspartic proteases), but also 
includes coumarin which inhibits granzyme B which is particularly abundant in blood 
cells. 
5. We had traditionally used PMSF (phenylmethylsulfonyl fluoride) because it is 
much less expensive and large volumes are needed for the procedure.  However, we 
have found that some batches tend to precipitate and form crystals when added to the 
solutions and when this happens we have observed nuclei/ NEs aggregating on these 
crystals under the microscope.  Thus, if using PMSF crystal formation should be 
tested for each batch prior to its use in the procedure.  When used, it can be added 
from a 100 mM stock in EtOH. 
6. If general protease cocktails are used, it is important to make certain that they do 
not contain EDTA as this has been reported to negatively affect NE preparation. 
7. The solution can be prepared by adding 220 ml of a 2.5 M (85%) sucrose stock to 
12.5 ml 1 M HEPES, 6.25 ml 1 M KCl, 1.25 ml 1 M MgCl2, and 10 ml H2O. 
8. Phenomenex now recommends the use of “Synergi Hydro-RP as an improved 
alternative to Aqua 125Å”. 
9. Bulk material is not available. The resin is extracted from the HPLC column (cut in 
half with hacksaw), washed with methanol, dried, and stored as a powder. 
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10. Chapters detailing modifications of the NE protocol for rodent liver and muscle 
are being prepared for other volumes in the Methods in Molecular Biology series. 
11. As with most protocols there is an optimal middle ground with too little or too 
much starting material resulting in lower yields.  Because of the timing of centrifuge 
steps and layering gradients, one person can only easily manage two buffy coats at a 
time; however, four can easily be processed in a day in two sets.  It is useful to 
increase the total number of blood packs used for a NE prep as it is difficult to see the 
nuclear pellets after pelleting through the sucrose cushions, but the use of too much 
starting material can saturate the sucrose gradients.  The maximum capacity of the 
SW28 rotor used in this procedure would be approximately eight buffy coats. 
12. This is an excess to ensure that a sufficient number of tubes are open to 
accommodate the volume in the bag (which is variable); only four are usually 
required. 
13. It is helpful when layering to tilt the tube at a 45° angle and direct the pipette tip at 
a right angle to the side of the tube so that the force of the flow is distributed over a 
wide area of the wall of the tube. 
14. Sometimes the cells will be clumped and sometimes also have a red tinge.  
Neither invalidates the prep.  However, if cells are in large clumps extra care should 
be made to disrupt them when resuspending, or rosette formation may occur in the 
next pelleting step and reduce yields.  The red tinge is due to erythrocyte 
contamination: if it is critical to remove all erythrocytes, then another ficoll gradient 
may be engaged after washing the cells with PBS and pelleting. 
15. The supernatant will appear cloudy: this is because it is dense with platelets and 
does not reflect a loss of leukocytes/ lymphoctyes. 
16. If the supernatant still appears cloudy, this step can be repeated. 
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17. The pellet resuspends with less clumping when using a small volume (i.e. 5-7 ml) 
before transferring  cells into 75 cm2 tissue culture flasks. 
18. If processing bloods from multiple donors, it is important to keep each blood 
separate until after the hypotonic lysis. 
19. Care must be taken to remove as much supernatant as possible in order to reduce 
highly concentrated proteins from serum that could block swelling in step 4. 
20. The cells are distributed thus, so each tube can be successively resuspended in 
hypotonic lysis buffer in step 4 to maintain an identical swell time for each douncing. 
21. As many protease inhibitors are short-lived, it is important to add them fresh to 
buffers shortly before use throughout the procedure. 
22. We have noted that each blood takes a different amount of time for the cells to 
swell.  Thus 10 min is a guideline, but not an absolute. 
23. It is important to stagger the pellets because protracted incubation of the cells in 
hypotonic buffer will also lyse nuclei. 
24. This serves to stabilize the nuclei as otherwise they also will swell and lyse during 
the subsequent steps, particularly the long incubation in the sucrose gradients. 
25. The 50 ml volume assumes that cells from 1-2 buffy coats are being processed.  If 
more are being processed, the pellets should be resuspended so that (based on initial 
cell counts and assuming full recovery thus far) no less than 50 million and no more 
than 200 million nuclei are loaded per SW28 tube (25 ml). 
26. Contaminating ER and other membranes that are rich in proteases have floated in 
the sucrose away from the nuclear pellet and these now line the walls of the tube.  
Therefore it is important to avoid contact between the protease rich walls and the 
pellet.  It is also important to keep the tubes inverted in the cold room after pouring 
29 
off the supernatant until the sides can be wiped in order to prevent the remaining film 
collecting by gravity in the bottom of the tube. 
27. It is very important to use a swinging bucket rotor when spinning through the 
sucrose cushion at this point in order to float any chromatin that is released away from 
the NEs.  In a fixed-angle rotor the cushion will be distributed thinly and NEs will 
have more chromatin contamination. 
28. The supernatant may appear slightly cloudy, but this is mostly chromatin that has 
been ejected and should give a dark, worm-like appearance under the microscope 
quite distinct from NEs. 
29. Faster speeds with shorter times may be used in microcentrifuge tubes provided 
that the NEs are not intended for ultrastructural analysis. 
30. The pellet here will typically be much larger than the nuclear pellet. 
31. Although the membranes are floated better using a swinging bucket rotor, a fixed 
angle rotor can also be used  (e.g. type 45 Ti).  In this case, volumes should be 
increased to 35 ml of the diluted membranes, 9.5 ml of the 1.86 M SHKM, and 3 ml 
of the 0.25 M SHKM.  This final volume fills the tubes sufficiently to minimize the 
chance of tube collapse, while minimizing the chance of leakage into the rotor.  
Centrifuge at 57,000 x g (~27,000 rpm) for 5 h. 
32. The type 45 Ti rotor tubes must be filled to close to the top or they can collapse. 
33. Microsome protein levels comprise a less predictable fraction of the starting 
material as compared to NEs. Therefore amounts are determined by either Coomassie 
staining on SDS-PAGE or by an alternative protein quantitation assay. 
34. It is critical to start the centrifugation step immediately since, loss of membrane 
proteins was observed even after just 10 min of additional incubation on ice. 
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35. The pellet should be very hard, so there is no need to recentrifuge after adding the 
H2O. 
36. Tansfering from an 1.5 ml eppendorf tube to a larger volume tube is to avoid 
losing sample during the bubbling that occurs because of the neutralization process. 
37. At this step, because of the large volume (~850 µl), the sample will have to be 
split into three aliqots of ~1150 µl in 1.5 ml eppendorf tubes. 
38. This makes for a pretty redundant list of proteins, but not all protein sequences 
have been predicted in the annotated human genome and sometimes missing proteins 
will appear in another related organism. 
39. We have used TMHMM since the second version has become available, but used 
TMPred earlier because the first version of TMHMM failed correctly to predict 
several of the well-characterized NETs.  It is wise to compare the results from 
different algorithms and to search for multimers of beta barrels as well as 
transmembrane helices. 
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Legends to Figures and Tables 
 
 
Fig. 1.  Swelling of lymphoctyes for hypotonic lysis.  A.  Cells prior to treatment.  
Nuclei make the greater part of cell mass.  B.  The same cells after swelling in 
hypotonic lysis buffer.  Note that some cells have burst even without Dounce 
homogenization.  It is critical to Dounce the cells quickly at this stage and make the 
solution isotonic or the nuclei will also swell and burst.  
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Fig. 2.  Schematic detailing the addition of sucrose cushions.  After distributing the 
nuclei-enriched lysate into SW28 ultracentrifuge tubes, a long large bore needle is 
inserted to the base of the tube to underlay with high sucrose buffer.  Because of the 
high viscosity of the 2.2 M sucrose solution, it is important to use a needle of at least 
14 gauge: it takes several minutes to underlay each tube if an 18 gauge needle is used 
compared to 30 seconds with a 14 gauge.  It is important to use a luer lock syringe 
because the viscosity of the solution can produce high pressure on the connection. 
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Fig. 3.  Removal of nucleoplasmic contents to make NEs.  A.  Isolated nuclei before 
nuclease treatment.  B.  Nuclei after chromatin digestion.  Note the change from phase 
dense to phase lucent.  When the cells have reached this stage, the digestion is 
complete and pelleting yields the final NE fraction.  C and D. DNA staining.  Isolated 
nuclei (C) and NEs (D) are also depicted by fluorescence microscopy after staining 
with Hoechst 33342.  Most of the DNA staining has disappeared from the chromatin-
digested NEs. 
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Fig. 4.  Structures of chemicals used to extract NEs.  A.  The three detergents used 
have very different structures.  Empigen BB is a zwitterionic detergent that was used 
in a recent proteomics study, where it was reported to preferentially solubilize nuclear 
pore complex core proteins (33).  As a Zwitterionic detergent it has both properties of 
non-ionic and ionic detergents.  Both octyl ß-D-glucopyranoside (also called octyl 
glucoside) and Triton X-100 are non-ionic detergents.  Octyl glucoside has a 
glycosidic head group, while Triton X-100 has a polyoxyethylene head group.  The 
non-ionic detergents are generally thought to be better suited to break lipid-protein 
interactions than protein-protein interactions.  They also have the advantage of being 
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unaffected by the concentration of salt, which enables further removal of chromatin 
contaminants from the NEs.  B.  Alkaline and chaotrope stuctures for NaOH and urea 
respectively.     
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Fig. 5.  Comparison of leukocyte/ lymphocyte NEs extracted with Na2CO3/ urea 
(chaotrope), NaOH (alkaline), Empigen BB, ß-octyl glucoside, or Triton X-100.  
Extracted proteins were resolved by SDS-PAGE (loading 0.5 million starting NEs per 
lane on BioRad 15-well mini-gels), transferred to PVDF membranes, and reacted with 
antibodies to either lamin B1 or the integral membrane proteins of the inner nuclear 
membrane emerin.  The chaotrope and alkaline treatments removed most lamins, 
while detergents had little effect.  In contrast, chaotrope and alkaline treatments had 
little effect on emerin, yet each detergent extracted this integral protein to a different 
degree with the most protein remaining after extraction with octylglucoside.  More 
emerin was removed by Triton X-100 extraction than by any other treatment.  This 
parallels results from the first proteomic analysis of NETs in which emerin was not 
identified in a Triton-extracted fraction, but was in the chaotrope-extracted fraction 
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(22).  In that same study, another integral inner nuclear membrane protein (LBR) was 
lost from the chaotrope-extracted fraction and retained in the Triton-extracted 
fraction.   
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Fig. 6.  Split-3-phase microcapillary column: Packing, Loading and Setup in 
LC/LC/MSfMS Mode. A.  Two 250 µm fused silica tubing are connected via a 
filtered union.  One end of the set up (on the frit side) is inserted into a high pressure 
deviced and packed using Helium pressure with SCX material in a slurry.  B.  The 
column is loaded with a slurry of Aqua C-18 RP, then washed with Methanol and 
Buffer A.  C.  The complex peptide mixture is pressure-loaded onto the 250 µm 
column.  D.  A pulled 100 µm single phase column is connected to the loaded and 
washed 2-phase column, and installed in-line with a quaternary HPLC pump and a 
tandem mass spectrometer. 
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Table 1: Gradient profiles for a 12-step MudPIT chromatography 
Step # 
Time 
(min) 
Buffer A 
(%) 
Buffer B 
(%) 
Buffer C 
(%) 
1 0 100 0 0 
1 16 60 40 0 
1 17 0 100 0 
1 20 0 100 0 
2 through 10 0 100 0 0 
2 through 10 3 100 0 0 
2 through 10 3.1 98 0 X* 
2 through 10 5 98 0 X* 
2 through 10 5.1 100 0 0 
2 through 10 10 100 0 0 
2 through 10 10.1 100 0 0 
2 through 10 25 85 15 0 
2 through 10 117 55 45 0 
11 and 12 0 100 0 0 
11 and 12 2 100 0 0 
11 and 12 2.1 0 0 100 
11 and 12 22 0 0 100 
11 and 12 22.1 100 0 0 
11 and 12 27 100 0 0 
11 and 12 37 80 20 0 
11 and 12 85 30 70 0 
11 and 12 90 0 10 0 
11 and 12 90.1 0 10 0 
11 and 12 95 0 10 0 
11 and 12 95.1 100 0 0 
11 and 12 97 100 0 0 
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* X is equal to 5, 10, 15, 20, 30, 40, 50, 60 and 80 % C is steps 2 through 10, 
respectively. 
 
 
Table 2: Filtering criteria applied to spectrum/peptide matches and proteins 
Parameter Value 
Minimum +1 XCorr 1.8 
Minimum +2 XCorr 2.5 
Minimum +3 XCorr 3.5 
Minimum DeltCN 0.08 
Minimum charge state 1 
Maximum charge state 3 
Maximum Sp rank 10 
Tryptic status requirement Any 
Multiple, ambiguous IDs allowed FALSE 
Preceding residue must be one of KRM 
Minimum sequence length 7 
Maximum sequence length 100 
Purge duplicate peptides by protein XCorr 
Include only loci with unique peptide FALSE 
Remove subset proteins FALSE 
Exclude protein names matching Contaminant 
Exclude protein descriptions matching KERATIN 
Minimum redundancy for low coverage loci 10 
Minimum peptides per locus 1 
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